The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3

Autor: Miller, T.J., McCoy, M.J., Hemmings, C., Bulsara, M.K., Iacopetta, B., Platell, C.F.
Zdroj: In Pathology December 2017 49(7):721-730
Databáze: ScienceDirect